RxDoctor Payments Data

Kurt Voos, MD

Orthopaedic Surgery of the Spine · Danville, VANPI 1619919115

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (52.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. GS Solutions, Inc. accounts for 77.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $4,552, more than ten times the $245 reported in 2019. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in VA, where the typical reported total is $18,012.

$11,476in general payments, 2019–2025

Across 51 payments — averaging $225.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GS Solutions, Inc.$9K
  • Spineology Inc.$2K
  • Abbott$644
  • Intrinsic Therapeutics$127
  • Amgen$83
  • Smith+Nephew$63
  • plus $119 from 3 others
$313,943in research payments, 2019–2025

Across 12 payments — averaging $26,162 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biom'up France SAS$232K
  • GS Solutions, Inc.$82K

What the payments were for

  • Royalty or licence$6,04153%
  • Consulting fees$1,60014%
  • Travel & lodging$6456%
  • Food & beverage$3,19028%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,476 in reported general payments places this provider in the 35th percentile of 43 orthopaedic surgery of the spine providers in Virginia.

See all orthopaedic surgery of the spine providers in Virginia

Medicare billing

Part B allowed, 2024
$608,561
Medicare patients
365
Services billed
3,818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen380$4,152
Gabapentin411$3,999
Prednisone235$3,818
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen304$2,579
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen102$1,604
Pregabalin72$1,010
Cyclobenzaprine Hcl67$877
Diclofenac Sodium54$466
Methylprednisolone66$340
Acetaminophen-CodeineAcetaminophen With Codeine28$319
Meloxicam117$318
Tramadol Hcl123$293
Celecoxib14$169
Tizanidine Hcl11$153
Cephalexin16$90

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Danville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →